Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature.
about
The emerging role of histone lysine demethylases in prostate cancerIdentification of CBX3 and ABCA5 as putative biomarkers for tumor stem cells in osteosarcomaEpigenetic regulation of CpG promoter methylation in invasive prostate cancer cellsMelanoma spheroids grown under neural crest cell conditions are highly plastic migratory/invasive tumor cells endowed with immunomodulator functionCancer Stem Cells and Epithelial-to-Mesenchymal Transition (EMT)-Phenotypic Cells: Are They Cousins or Twins?Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancerThe role of CD44 in epithelial-mesenchymal transition and cancer developmentProstate Cancer Stem Cells: Research AdvancesA comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responsesThe cancer stem cell niche--there goes the neighborhood?The Regulatory Role of MicroRNAs in EMT and CancerResveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transitionIn vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147Prostate cancer stem cell-targeted efficacy of a new-generation taxoid, SBT-1214 and novel polyenolic zinc-binding curcuminoid, CMC2.24Establishment of highly tumorigenic human colorectal cancer cell line (CR4) with properties of putative cancer stem cellsNANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation.A novel patient-derived intra-femoral xenograft model of bone metastatic prostate cancer that recapitulates mixed osteolytic and osteoblastic lesions.Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cellsPathobiological implications of the expression of EGFR, pAkt, NF-κB and MIC-1 in prostate cancer stem cells and their progeniesEpithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle?Cytotoxic effects induced by docetaxel, gefitinib, and cyclopamine on side population and nonside population cell fractions from human invasive prostate cancer cells.Genomic profiling of tumor initiating prostatospheres.Sulforaphane and TRAIL induce a synergistic elimination of advanced prostate cancer stem-like cellsMore than markers: biological significance of cancer stem cell-defining molecules.CD133, Trop-2 and alpha2beta1 integrin surface receptors as markers of putative human prostate cancer stem cells.GLI1 confers profound phenotypic changes upon LNCaP prostate cancer cells that include the acquisition of a hormone independent stateNew promising drug targets in cancer- and metastasis-initiating cells.Activation of c-MET induces a stem-like phenotype in human prostate cancerThe dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition.Frequent deregulations in the hedgehog signaling network and cross-talks with the epidermal growth factor receptor pathway involved in cancer progression and targeted therapies.A 1536-well quantitative high-throughput screen to identify compounds targeting cancer stem cells.Histone deacetylase inhibitors induce epithelial-to-mesenchymal transition in prostate cancer cells.Sulforaphane increases drug-mediated cytotoxicity toward cancer stem-like cells of pancreas and prostate.The role of epithelial plasticity in prostate cancer dissemination and treatment resistanceHedgehog overexpression leads to the formation of prostate cancer stem cells with metastatic property irrespective of androgen receptor expression in the mouse modelDissociated primary human prostate cancer cells coinjected with the immortalized Hs5 bone marrow stromal cells generate undifferentiated tumors in NOD/SCID-γ mice.Membrane Type 1 Matrix Metalloproteinase induces an epithelial to mesenchymal transition and cancer stem cell-like properties in SCC9 cells.Androgen receptor splice variants contribute to prostate cancer aggressiveness through induction of EMT and expression of stem cell marker genes.DNA repair: the culprit for tumor-initiating cell survival?Identification of vitronectin as an extrinsic inducer of cancer stem cell differentiation and tumor formation.
P2860
Q21245762-580E9391-3C76-4542-97EC-92D91D93C7D0Q21560783-9977511F-9545-4963-9315-BAED721B6C38Q24302022-3DDC437C-4CB0-432A-9A24-479751523EE2Q24614044-C659FBF0-8D16-4716-B41D-A9033B67FCD7Q24628819-554BF058-BF61-4328-BC5F-114F3037A819Q24632276-0B058D54-98B5-4676-BC57-43DB45661245Q26771509-EE6204A7-1F05-4D3B-9552-B590DA2213A3Q26998435-5637DF42-AA6F-4F1E-8E19-04BC643632E2Q27329871-D88A4818-A10F-4219-B13D-D42A9D371377Q28244178-BE314903-9C9E-4DAE-8FC5-9463D9394392Q28391426-14F3458A-3917-44C5-9136-33637DE2BEA7Q28477031-5FE1F5C0-C539-489C-9273-D25C98BEBB4AQ28482047-BF95F8DF-FF3B-4097-B6AB-6F2605BDEBC7Q28533786-BE7B23F9-381E-4217-8860-900C60CB197BQ28539620-03B1D5DA-0247-48CD-BDD5-ACA03B82AE96Q30502706-973F5887-EC9C-40CD-BFAB-79AF46F6600DQ30504566-179BC523-C451-4593-9395-806A50B987F2Q30988612-AEDB685A-5483-4383-9508-D4CF9CC9A01EQ31049380-DDE33994-F948-4E05-9DF7-D557C92D354DQ33351622-8BD83EF7-6816-4487-A5F6-11A3CF9F2233Q33533700-5093DBC0-2EFE-402E-8538-068F4E5ECBACQ33586722-106D3006-5AE5-4750-AF0E-920439911F68Q33637076-4881A7D1-039E-4345-A57A-D33307DD276CQ33661278-3E1AFBF3-B878-441D-8192-823FFCFD86ADQ33793473-2EC7A659-FF5A-4BB2-8C59-A82092E90857Q33919758-AA61298F-E7EA-4DD2-9061-73DCB99881EFQ34003691-A384DEC9-2A48-49E9-BFA6-F56EAD5C456CQ34081431-9177D2C6-6554-4B6B-9783-F0E722372268Q34105402-9D1959F2-62DB-48DC-ABDA-BDE2106FF180Q34244929-7CD18DAF-4E0D-4D96-A913-29975F644611Q34395138-7754765C-FE80-4248-BF51-2DFCF707ED18Q34425201-5EE7A720-E3F7-4E3C-B1C4-A45D3F3D60BEQ34473316-FD5238A9-CF62-41C3-BE05-B88E496ABB69Q34505037-66D9B18F-386B-4429-96BE-202F50123FBCQ34515977-1B1A8320-4CA6-425F-B005-06478F53250DQ34602712-238016BE-0562-43E3-88C0-9052D88C8735Q34645532-ECD5645C-C4D4-4248-AB46-A3E641F9D8F3Q34734595-68D3B22B-A8AC-413E-A001-AD7FC6824CF9Q34804212-AA8DCD8F-A662-440F-8D50-587D79DCA500Q35016861-C19170EB-6575-4765-BAD9-D18E6A06A0AA
P2860
Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Invasive prostate cancer cells ...... m cell-like genomic signature.
@en
Invasive prostate cancer cells ...... m cell-like genomic signature.
@nl
type
label
Invasive prostate cancer cells ...... m cell-like genomic signature.
@en
Invasive prostate cancer cells ...... m cell-like genomic signature.
@nl
prefLabel
Invasive prostate cancer cells ...... m cell-like genomic signature.
@en
Invasive prostate cancer cells ...... m cell-like genomic signature.
@nl
P2093
P2860
P1476
Invasive prostate cancer cells ...... m cell-like genomic signature.
@en
P2093
Elaine M Hurt
George J Klarmann
Lesley A Mathews
Maria A Duhagon
Suneetha B Thomas
Tashan Mistree
William L Farrar
Xiaohu Zhang
P2860
P2888
P304
P356
10.1007/S10585-009-9242-2
P577
2009-02-17T00:00:00Z